Drug intelligence / Profile preview

scutellarin

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Scutellarin is a flavonoid glucuronide, specifically the 7-O-glucuronide of scutellarein, found primarily in the traditional Chinese medicinal plants *Erigeron breviscapus* and *Scutellaria barbata*. It is the principal active component of breviscapine tablets. Scutellarin exhibits a broad spectrum of pharmacological activities, including antioxidant, anti-inflammatory, anti-apoptotic, vasodilatory, antiplatelet, anticoagulant, and myocardial protective effects. Mechanistically, it modulates multiple biological pathways such as oxidative stress reduction (antioxidant), inhibition of inflammatory mediators (anti-inflammatory), prevention of cell death (anti-apoptotic), vascular relaxation (vasodilatory), and inhibition of platelet aggregation and coagulation cascades. It also inhibits cytochrome P450 3A activity and has been shown to interact with tumor necrosis factor receptor II on regulatory T cells in cancer models. Clinically and preclinically studied for cerebrovascular diseases (e.g., stroke), cardiovascular diseases (e.g., myocardial infarction), diabetic complications (notably diabetic retinopathy), neurodegenerative disorders, metabolic diseases, organ injury protection after ischemia/reperfusion events, as well as anticancer properties against various tumor types[1][2][3][4][6].

Brand names
breviscapine
Other names
scutellarein-7-glucuronidescutellarein7-glucuronidescutellarein 7-glucuronidescutellarein-7beta-D-glucuronidescutellarein7beta-D-glucuronidescutellarein 7beta-D-glucuronidescutellarin B
02

Targets

TNFR2 (Tumor necrosis factor receptor superfamily member 1B)OATP (Organic anion transporting polypeptides)SLCO1B3 (Organic anion transporting polypeptide 1B3)CYP3A (CYP3A family)

Beyond the preview

Go deeper on scutellarin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on scutellarin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call